These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 19491545
1. Beta-blockers in the treatment of hypertension: are there clinically relevant differences? Weir MR. Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545 [Abstract] [Full Text] [Related]
2. The role of the new beta-blockers in treating cardiovascular disease. Weber MA. Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [Abstract] [Full Text] [Related]
3. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade. Bakris G. J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898 [Abstract] [Full Text] [Related]
4. Should beta-blockers be used to control hypertension in people with chronic kidney disease? Hart PD, Bakris GL. Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793 [Abstract] [Full Text] [Related]
5. [Role of the L-arginine/nitric oxide system in the action of nebivolol]. Brodde OE, Philipp T. Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442 [Abstract] [Full Text] [Related]
9. Effects of beta-blockers on glucose and lipid metabolism. Fonseca VA. Curr Med Res Opin; 2010 Mar 10; 26(3):615-29. PubMed ID: 20067434 [Abstract] [Full Text] [Related]
10. Nitric oxide mechanisms of nebivolol. Maffei A, Lembo G. Ther Adv Cardiovasc Dis; 2009 Aug 10; 3(4):317-27. PubMed ID: 19443516 [Abstract] [Full Text] [Related]
11. Beta-blockers in hypertension. Ram CV. Am J Cardiol; 2010 Dec 15; 106(12):1819-25. PubMed ID: 21126627 [Abstract] [Full Text] [Related]
12. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff. Epstein BJ, Anderson S. Pharmacotherapy; 2007 Sep 15; 27(9):1322-33. PubMed ID: 17723086 [Abstract] [Full Text] [Related]
14. Are we misunderstanding beta-blockers. Cruickshank JM. Int J Cardiol; 2007 Aug 09; 120(1):10-27. PubMed ID: 17433471 [Abstract] [Full Text] [Related]
15. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension? Kountz DS. Postgrad Med; 2009 Jan 09; 121(1):14-24. PubMed ID: 19179810 [Abstract] [Full Text] [Related]
17. Beta-blockers in the management of hypertension: focus on nebivolol. Wojciechowski D, Papademetriou V. Expert Rev Cardiovasc Ther; 2008 Apr 09; 6(4):471-9. PubMed ID: 18402537 [Abstract] [Full Text] [Related]
18. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension. Prichard BN, Saul PA. J Cardiovasc Pharmacol; 1990 Apr 09; 16 Suppl 5():S81-5. PubMed ID: 11527141 [Abstract] [Full Text] [Related]
19. Mode of action of beta-adrenergic blocking drugs in hypertension. Prichard BN, Owens CW. Clin Physiol Biochem; 1990 Apr 09; 8 Suppl 2():1-10. PubMed ID: 1982756 [Abstract] [Full Text] [Related]
20. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension]. van den Born BJ, Brewster LM, Koopmans RP, van Montfrans GA. Ned Tijdschr Geneeskd; 2005 Aug 06; 149(32):1808-9. PubMed ID: 16121668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]